ID27562A - Turunan-turunan kinolin-2-ona tersubstitusi alkunil yang berguna sebagai zat anti kanker - Google Patents

Turunan-turunan kinolin-2-ona tersubstitusi alkunil yang berguna sebagai zat anti kanker

Info

Publication number
ID27562A
ID27562A IDW20010457A ID20010457A ID27562A ID 27562 A ID27562 A ID 27562A ID W20010457 A IDW20010457 A ID W20010457A ID 20010457 A ID20010457 A ID 20010457A ID 27562 A ID27562 A ID 27562A
Authority
ID
Indonesia
Prior art keywords
alkunil
kinolin
anti cancer
cancer substances
ona
Prior art date
Application number
IDW20010457A
Other languages
English (en)
Indonesian (id)
Inventor
Susan Deborah La Greca
Joseph Peter Lyssikatos
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of ID27562A publication Critical patent/ID27562A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IDW20010457A 1998-08-27 1999-08-06 Turunan-turunan kinolin-2-ona tersubstitusi alkunil yang berguna sebagai zat anti kanker ID27562A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9814598P 1998-08-27 1998-08-27

Publications (1)

Publication Number Publication Date
ID27562A true ID27562A (id) 2001-04-12

Family

ID=22267481

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20010457A ID27562A (id) 1998-08-27 1999-08-06 Turunan-turunan kinolin-2-ona tersubstitusi alkunil yang berguna sebagai zat anti kanker

Country Status (40)

Country Link
US (3) US6150377A (fr)
EP (1) EP1107963B1 (fr)
JP (1) JP3495706B2 (fr)
KR (1) KR20010072991A (fr)
CN (1) CN1314904A (fr)
AP (1) AP2001002079A0 (fr)
AT (1) ATE321037T1 (fr)
AU (1) AU4925499A (fr)
BG (1) BG105365A (fr)
BR (1) BRPI9913138B8 (fr)
CA (2) CA2341690C (fr)
CO (1) CO5130017A1 (fr)
CZ (1) CZ2001660A3 (fr)
DE (1) DE69930518T2 (fr)
DZ (1) DZ2880A1 (fr)
EA (1) EA200100135A1 (fr)
EE (1) EE200100118A (fr)
ES (1) ES2259237T3 (fr)
GE (1) GEP20033001B (fr)
GT (1) GT199900140A (fr)
HK (1) HK1039123A1 (fr)
HR (1) HRP20010142A2 (fr)
HU (1) HUP0103228A3 (fr)
ID (1) ID27562A (fr)
IL (1) IL141239A0 (fr)
IS (1) IS5818A (fr)
MA (1) MA26680A1 (fr)
NO (1) NO20010964L (fr)
NZ (1) NZ509372A (fr)
OA (1) OA11645A (fr)
PA (1) PA8480101A1 (fr)
PE (1) PE20000986A1 (fr)
PL (1) PL346426A1 (fr)
SK (1) SK2442001A3 (fr)
SV (1) SV1999000141A (fr)
TN (1) TNSN99162A1 (fr)
TR (1) TR200101343T2 (fr)
UY (1) UY25682A1 (fr)
WO (1) WO2000012499A1 (fr)
ZA (1) ZA200101173B (fr)

Families Citing this family (87)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030114503A1 (en) * 1997-06-16 2003-06-19 Pfizer Inc. Farnesyl transferase inhibitors in combination with HMG CoA reductase inhibitors for the treatment of cancer
HRP20000904A2 (en) * 1998-07-06 2001-12-31 Janssen Pharmaceutica Nv Farnesyl protein transferase inhibitors for treating arthropathies
KR20010072991A (ko) * 1998-08-27 2001-07-31 실버스타인 아써 에이. 항암제로서 유용한 알키닐-치환된 퀴놀린-2-온 유도체
CA2341739C (fr) * 1998-08-27 2005-07-12 Pfizer Products Inc. Derives de quinolin-2-one utiles en tant qu'agents anticancereux
TR200201296T2 (tr) 1999-02-11 2002-07-22 Pfizer Products Inc. Antikanser maddeleri olarak faydalı heteroaril-ikame edilmiş kinolin-2-on türevleri
HN2000000266A (es) 2000-01-21 2001-05-21 Pfizer Prod Inc Compuesto anticanceroso y metodo de separacion de enantiomeros util para sintetizar dicho compuesto.
JP2003523381A (ja) 2000-02-24 2003-08-05 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 投与レジメン
JO2361B1 (en) * 2000-06-22 2006-12-12 جانسين فارماسيوتيكا ان. في Enaniumer 1,2-anylated quinoline inhibitor for the transporter - farnesyl
ATE409189T1 (de) * 2000-09-25 2008-10-15 Janssen Pharmaceutica Nv Farnesyl transferase-hemmende 6- heterocyclylmethyl-chinolin und chinazol-derivate
WO2002024683A1 (fr) 2000-09-25 2002-03-28 Janssen Pharmaceutica N.V. Derives de la quinoleine et de la quinazoline 6-[(phenyle substitue)methyle] inhibiteurs de la farnesyle transferase
US7053105B2 (en) 2000-09-25 2006-05-30 Janssen Pharmaceutica, N.V. Farnesyl transferase inhibiting quinoline and quinazoline derivatives as farnesyl transferase inhibitors
JP4974439B2 (ja) * 2000-09-25 2012-07-11 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ ファルネシルトランスフェラーゼを阻害する６−ヘテロシクリルメチルキノリノン誘導体
ES2328225T3 (es) 2000-11-21 2009-11-11 Janssen Pharmaceutica Nv Derivados benzoheterociclicos inhibidores de la farnesil-transferasa.
EP1395577A1 (fr) 2000-12-19 2004-03-10 Pfizer Products Inc. Formes cristallines de sels de 6- (4-chloro-phenyl)-hydroxy-(3-methyl-3h-imidazol-4-yl)-methyl]-4-(3-ethynyl-phenyl)-1-methyl-1h-quinoleine-2-one, 2,3-dihydroxybutanedioate et procede de preparation
ATE319704T1 (de) 2000-12-27 2006-03-15 Janssen Pharmaceutica Nv Farnesyltransferase hemmende, in der 4-stellung substituierte chinolin- und chinazolinderivate
AU2002236813A1 (en) * 2001-01-22 2002-07-30 Schering Corporation Treatment of malaria with farnesyl protein transferase inhibitors
ES2236505T3 (es) * 2001-03-12 2005-07-16 Janssen Pharmaceutica N.V. Procedimiento para la preparacin de compuestos de imidazol.
US20020151563A1 (en) * 2001-03-29 2002-10-17 Pfizer Inc. Farnesyl transferase inhibitors in combination with HMG CoA reductase inhibitors for the inhibition of abnormal cell growth
WO2002080895A2 (fr) * 2001-04-06 2002-10-17 Schering Corporation Traitements antipaludiques comprenant l'administration d'inhibiteurs de la fasnesyl proteine transferase
EP1404329A4 (fr) * 2001-06-04 2006-11-02 Cytovia Inc Quinolinones 4-aryl-3-(3-aryl-1-oxo-2-propenyl)-2(1h)- substituees, et analogues utilises comme activateurs de caspases et inducteurs d'apoptose, et utilisation relative
WO2003000266A1 (fr) 2001-06-21 2003-01-03 Ariad Pharmaceuticals, Inc. Nouvelles quinoleines et leurs utilisations
US6740757B2 (en) 2001-08-29 2004-05-25 Pfizer Inc Enantiomers of 6-[(4-chloro-phenyl)-hydroxy-(3-methyl-3h-imidazol-4-yl)-methyl]-4-[3-(3-hydroxy-3-methyl-but-1-ynyl)-phenyl]-1-methyl-1h-quinolin-2-one and salts thereof, useful in the treatment of cancer
CA2469275C (fr) 2001-12-19 2011-09-06 Janssen Pharmaceutica N.V. Utilisation de derives de quinoline 1,8-anneles substitues avec des triazoles lies par le carbone en tant qu'inhibiteurs de farnesyl transferase
ES2287466T3 (es) 2002-03-22 2007-12-16 Janssen Pharmaceutica N.V. Derivados de 2-quinolinona y quinazolina de bencilimidazolil sustituidas como inhibidores de la farnesil transferasa.
CA2481480C (fr) 2002-04-15 2011-04-12 Janssen Pharmaceutica N.V. Derives de quinazoline tricylique inhibant la farnesyl transferase substitues avec des imidazoles ou des triazoles a liaison carbone
AU2003286321A1 (en) * 2002-12-19 2004-07-14 Pfizer Inc. 2-(1h-indazol-6-ylamino)-benzamide compounds as protein kinases inhibitors useful for the treatment of ophtalmic diseases
JP4691041B2 (ja) 2003-11-20 2011-06-01 チルドレンズ ホスピタル メディカル センター Ｇｔｐアーゼ阻害剤および使用方法
WO2005089515A2 (fr) * 2004-03-18 2005-09-29 The Brigham And Women's Hospital, Inc. Procedes de traitement des synucleinopathies
BRPI0509580A (pt) * 2004-03-30 2007-11-27 Pfizer Prod Inc combinações de inibidores de transdução de sinal
EP1786777A1 (fr) * 2004-08-26 2007-05-23 Pfizer, Inc. Composes aminoheteroaryles en tant qu'inhibiteurs des proteines tyrosine kinases
JP4242911B2 (ja) 2004-08-26 2009-03-25 ファイザー・インク プロテインキナーゼ阻害薬としてのエナンチオピュアなアミノヘテロアリール化合物
CA2577937C (fr) * 2004-08-26 2010-12-21 Pfizer Inc. Composes aminoheteroaryle a substitution pyrazole servant d'inhibiteurs de proteine kinase
PT1815247E (pt) 2004-11-05 2013-04-23 Janssen Pharmaceutica Nv Uso terapêutico de inibidores de farnesiltransferase e métodos para monitorizar a eficácia do mesmo
US20060107555A1 (en) * 2004-11-09 2006-05-25 Curtis Marc D Universal snow plow adapter
US20060281788A1 (en) 2005-06-10 2006-12-14 Baumann Christian A Synergistic modulation of flt3 kinase using a flt3 inhibitor and a farnesyl transferase inhibitor
WO2007016539A2 (fr) 2005-07-29 2007-02-08 Children's Hospital Medical Center Inhibiteurs de gtpase et methodes d'utilisation et structure cristalline de la gtpase rac-1
SI2447283T1 (sl) 2005-09-07 2015-12-31 Amgen Fremont Inc. Človeška monoklonska protitelesa proti aktivin receptorski kinazi-1 (ALK-1)
AU2006292278B2 (en) 2005-09-20 2012-03-08 Osi Pharmaceuticals, Inc. Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors
AU2006331542A1 (en) 2005-12-23 2007-07-05 Link Medicine Corporation Treatment of synucleinopathies
TW200812615A (en) 2006-03-22 2008-03-16 Hoffmann La Roche Tumor therapy with an antibody for vascular endothelial growth factor and an antibody for human epithelial growth factor receptor type 2
KR101367645B1 (ko) 2006-04-20 2014-02-27 얀센 파마슈티카 엔.브이. Ｃ-ｆｍｓ 키나제의 저해제로서의 복소환식 화합물
EP2016070B1 (fr) 2006-04-20 2016-01-13 Janssen Pharmaceutica N.V. Inhibiteurs de la c-fms kinase
US8697716B2 (en) 2006-04-20 2014-04-15 Janssen Pharmaceutica Nv Method of inhibiting C-KIT kinase
EA200802058A1 (ru) 2006-05-09 2009-06-30 Пфайзер Продактс Инк. Производные циклоалкиламинокислот и их фармацевтические композиции
AU2007287794B2 (en) 2006-08-21 2013-03-28 F. Hoffmann-La Roche Ag Tumor therapy with an anti-VEGF antibody
EP2155197A4 (fr) * 2007-03-09 2011-10-12 Link Medicine Corp Traitement des maladies de surcharge lysosomale
JO3240B1 (ar) 2007-10-17 2018-03-08 Janssen Pharmaceutica Nv c-fms مثبطات كيناز
WO2009151683A2 (fr) 2008-03-12 2009-12-17 Link Medicine Corporation Inhibiteurs de quinolinone farnésyl transférase pour le traitement de synucléinopathies et d'autres indications
DE102008022221A1 (de) * 2008-05-06 2009-11-12 Universität des Saarlandes Inhibitoren der humanen Aldosteronsynthase CYP11B2
US20100331363A1 (en) * 2008-11-13 2010-12-30 Link Medicine Corporation Treatment of mitochondrial disorders using a farnesyl transferase inhibitor
US20110060005A1 (en) * 2008-11-13 2011-03-10 Link Medicine Corporation Treatment of mitochondrial disorders using a farnesyl transferase inhibitor
AU2009313927A1 (en) 2008-11-13 2010-05-20 Astrazeneca Ab Azaquinolinone derivatives and uses thereof
US20120189641A1 (en) 2009-02-25 2012-07-26 OSI Pharmaceuticals, LLC Combination anti-cancer therapy
US20110171124A1 (en) 2009-02-26 2011-07-14 Osi Pharmaceuticals, Inc. In situ methods for monitoring the EMT status of tumor cells in vivo
WO2010099138A2 (fr) 2009-02-27 2010-09-02 Osi Pharmaceuticals, Inc. Procédés pour l'identification d'agents qui inhibent les cellules tumorales de type mésenchymateuses ou leur formation
US8642834B2 (en) 2009-02-27 2014-02-04 OSI Pharmaceuticals, LLC Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation
JP2012519282A (ja) 2009-02-27 2012-08-23 オーエスアイ・ファーマシューティカルズ，エルエルシー 間葉様腫瘍細胞またはその生成を阻害する薬剤を同定するための方法
AU2011223643A1 (en) 2010-03-03 2012-06-28 OSI Pharmaceuticals, LLC Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors
AU2011223655A1 (en) 2010-03-03 2012-06-28 OSI Pharmaceuticals, LLC Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors
WO2012116040A1 (fr) 2011-02-22 2012-08-30 OSI Pharmaceuticals, LLC Marqueurs biologiques prédictifs d'une réponse anticancéreuse aux inhibiteurs de la kinase du récepteur du facteur de croissance 1 analogue à l'insuline dans le carcinome hépatocellulaire
JP2014519813A (ja) 2011-04-25 2014-08-21 オーエスアイ・ファーマシューティカルズ，エルエルシー 癌薬剤発見、診断、および治療におけるｅｍｔ遺伝子シグネチャーの使用
WO2013152252A1 (fr) 2012-04-06 2013-10-10 OSI Pharmaceuticals, LLC Polythérapie antinéoplasique
US9980942B2 (en) 2012-05-02 2018-05-29 Children's Hospital Medical Center Rejuvenation of precursor cells
AU2013299922B2 (en) 2012-08-07 2018-06-21 Janssen Pharmaceutica Nv Process for the preparation of heterocyclic ester derivatives
ES2607807T3 (es) 2012-08-07 2017-04-04 Janssen Pharmaceutica Nv Procedimiento para la preparación de los inibidores de las quinasas c-fms
AR094403A1 (es) 2013-01-11 2015-07-29 Hoffmann La Roche Terapia de combinación de anticuerpos anti-her3
US10028503B2 (en) 2014-06-18 2018-07-24 Children's Hospital Medical Center Platelet storage methods and compositions for same
US10471055B2 (en) 2015-08-17 2019-11-12 Kura Oncology, Inc. Methods of treating cancer patients with farnesyltransferase inhibitors
WO2017096165A1 (fr) 2015-12-03 2017-06-08 Agios Pharmaceuticals, Inc. Inhibiteurs de mat2a pour le traitement du cancer n'exprimant pas mtap
US20190119758A1 (en) 2016-04-22 2019-04-25 Kura Oncology, Inc. Methods of selecting cancer patients for treatment with farnesyltransferase inhibitors
HRP20210544T1 (hr) 2016-11-03 2021-08-20 Kura Oncology, Inc. Inhibitori farneziltransferaze za uporabu u liječenju raka
EP3579872A1 (fr) 2017-02-10 2019-12-18 INSERM (Institut National de la Santé et de la Recherche Médicale) Procédés et compositions pharmaceutiques pour le traitement de cancers associés à l'activation de la voie mapk
WO2018156609A1 (fr) 2017-02-21 2018-08-30 Kura Oncology, Inc. Méthodes de traitement du cancer avec des inhibiteurs de la farnésyltransférase
US10137121B2 (en) 2017-02-21 2018-11-27 Kura Oncology, Inc. Methods of treating cancer with farnesyltransferase inhibitors
CA3071854A1 (fr) 2017-08-07 2019-02-14 Kura Oncology, Inc. Methodes de traitement du cancer avec des inhibiteurs de la farnesyltransferase
US10806730B2 (en) 2017-08-07 2020-10-20 Kura Oncology, Inc. Methods of treating cancer with farnesyltransferase inhibitors
WO2019113269A1 (fr) 2017-12-08 2019-06-13 Kura Oncology, Inc. Méthodes de traitement de patients cancéreux avec des inhibiteurs de la farnésyltransférase
AU2019372141A1 (en) 2018-11-01 2021-05-27 Kura Oncology, Inc. Methods of treating cancer with farnesyltransferase inhibitors
US20220071941A1 (en) 2018-12-21 2022-03-10 Kura Oncology, Inc. Therapies for squamous cell carcinomas
WO2020180663A1 (fr) 2019-03-01 2020-09-10 Kura Oncology, Inc. Méthodes de traitement du cancer à l'aide d'inhibiteurs de farnésyltransférase
US20220143006A1 (en) 2019-03-15 2022-05-12 Kura Oncology, Inc. Methods of treating cancer with farnesyltransferase inhibitors
WO2020205486A1 (fr) 2019-03-29 2020-10-08 Kura Oncology, Inc. Procédés de traitement de carcinomes squameux par des inhibiteurs de farnésyltransférase
TW202102218A (zh) 2019-04-01 2021-01-16 美商庫拉腫瘤技術股份有限公司 以法呢基(farnesyl)轉移酶抑制劑治療癌症的方法
GB201905721D0 (en) 2019-04-24 2019-06-05 Univ Dundee Compounds
US20220305001A1 (en) 2019-05-02 2022-09-29 Kura Oncology, Inc. Methods of treating acute myeloid leukemia with farnesyltransferase inhibitors
CN114450027A (zh) 2019-08-16 2022-05-06 儿童医院医疗中心 用cdc42特异性抑制剂治疗受试者的方法
WO2021155006A1 (fr) 2020-01-31 2021-08-05 Les Laboratoires Servier Sas Inhibiteurs de kinases dépendantes des cyclines et leurs utilisations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5747498A (en) * 1996-05-28 1998-05-05 Pfizer Inc. Alkynyl and azido-substituted 4-anilinoquinazolines
TW349948B (en) * 1995-10-31 1999-01-11 Janssen Pharmaceutica Nv Farnesyl transferase inhibiting 2-quinolone derivatives
DE69635966T2 (de) * 1995-12-08 2006-11-30 Janssen Pharmaceutica N.V. (Imidazol-5-yl)Methyl-2-Chinolinonderivate als Farnesyl Protein transferase Inhibitoren
KR20010072991A (ko) * 1998-08-27 2001-07-31 실버스타인 아써 에이. 항암제로서 유용한 알키닐-치환된 퀴놀린-2-온 유도체

Also Published As

Publication number Publication date
ES2259237T3 (es) 2006-09-16
CA2341690A1 (fr) 2000-03-09
EP1107963B1 (fr) 2006-03-22
CZ2001660A3 (cs) 2002-05-15
US6294552B1 (en) 2001-09-25
HUP0103228A2 (hu) 2002-02-28
DE69930518D1 (de) 2006-05-11
HUP0103228A3 (en) 2003-01-28
GT199900140A (es) 2001-02-14
WO2000012499A1 (fr) 2000-03-09
ATE321037T1 (de) 2006-04-15
DZ2880A1 (fr) 2003-12-15
CA2341690C (fr) 2007-04-17
MA26680A1 (fr) 2004-12-20
IS5818A (is) 2001-01-19
SK2442001A3 (en) 2002-10-08
JP3495706B2 (ja) 2004-02-09
US6150377A (en) 2000-11-21
NO20010964D0 (no) 2001-02-26
BRPI9913138B8 (pt) 2016-05-17
AP2001002079A0 (en) 2001-03-31
PL346426A1 (en) 2002-02-11
UY25682A1 (es) 2000-03-31
CA2578326A1 (fr) 2000-03-09
ZA200101173B (en) 2002-04-12
NZ509372A (en) 2003-08-29
PE20000986A1 (es) 2000-09-30
GEP20033001B (en) 2003-06-25
CO5130017A1 (es) 2002-02-27
EA200100135A1 (ru) 2001-08-27
US20020128287A1 (en) 2002-09-12
CN1314904A (zh) 2001-09-26
EE200100118A (et) 2002-06-17
BG105365A (en) 2001-11-30
EP1107963A1 (fr) 2001-06-20
PA8480101A1 (es) 2003-06-30
IL141239A0 (en) 2002-03-10
CA2578326C (fr) 2009-11-24
HK1039123A1 (zh) 2002-04-12
TR200101343T2 (tr) 2001-09-21
NO20010964L (no) 2001-04-26
TNSN99162A1 (fr) 2005-11-10
JP2002523504A (ja) 2002-07-30
HRP20010142A2 (en) 2002-02-28
AU4925499A (en) 2000-03-21
BR9913138B1 (pt) 2013-11-05
KR20010072991A (ko) 2001-07-31
SV1999000141A (es) 2000-07-06
OA11645A (en) 2004-11-16
US6579887B2 (en) 2003-06-17
BR9913138A (pt) 2001-05-08
DE69930518T2 (de) 2006-09-21

Similar Documents

Publication Publication Date Title
ID29584A (id) Turunan-turunan kuinolin-2-on tersubstitusi heteroaril yang bermanfaat sebagai zat-zat anti kanker
ID27006A (id) Turunan-turunan isotiazol yang bermanfaat sebagai zat anti kanker
ID30176A (id) Senyawa-senyawa yang bermanfaat sebagai zat anti-inflamasi
ID22733A (id) Bahan penyerap zat keluaran tubuh
ID28502A (id) Polisakarida mikrofibrilar yang diderivatisasi
ID25977A (id) Popok sekali pakai
ID24555A (id) Popok sekali pakai
LTC1124961I2 (lt) Trombopoetino junginiai
ATE229954T1 (de) Betacarbolinverbindungen
DE59913497D1 (de) Schleifgerät
DE69925322D1 (de) Polymerisierbare Zusammensetzung
ID28266A (id) Senyawa-senyawa amidin
NO20005488D0 (no) Hematopoetisk stimulering
DE69712736D1 (de) Cholesterische flocke
DE69909878D1 (de) Filtervorrichtung
ID28692A (id) Turunan benzena dilebur yang berguna sebagai herbisida
FI980369A0 (fi) Foerfarande och anordning foer hoejning av uppvaermningen i en haerdningsugn foer glasskivor
NO20011745L (no) Forbindelser
DE60035460D1 (de) In-Line Teilchendetektor
FI4209U1 (fi) Uusia yhdisteitä
ID30114A (id) Zat-zat herbisida dengan fenoksisulfonilurea tersubstitusi
NO20004079L (no) Roterende filter
ID27004A (id) Senyawa-senyawa kalsilitik
DE59912091D1 (de) Filtervorrichtung
ID29268A (id) Senyawa spiro yang bersifat antihistamin